Barbara Langen

1.2k total citations
21 papers, 836 citations indexed

About

Barbara Langen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Barbara Langen has authored 21 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 4 papers in Cognitive Neuroscience. Recurrent topics in Barbara Langen's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Receptor Mechanisms and Signaling (5 papers). Barbara Langen is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Receptor Mechanisms and Signaling (5 papers). Barbara Langen collaborates with scholars based in Germany, Japan and Italy. Barbara Langen's co-authors include Rita Dost, Nereo Kalebic, Wieland Β. Huttner, Katherine R. Long, Pauline Wimberger, Ute Egerland, Heidrun Fink, Marta Florio, Takashi Namba and Carlotta Gilardi and has published in prestigious journals such as Neuron, Cell stem cell and Journal of Medicinal Chemistry.

In The Last Decade

Barbara Langen

21 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Langen Germany 11 535 225 169 149 91 21 836
Matthew R. Livesey United Kingdom 20 764 1.4× 627 2.8× 57 0.3× 210 1.4× 58 0.6× 37 1.3k
Imane Moutkine France 17 537 1.0× 703 3.1× 81 0.5× 162 1.1× 91 1.0× 26 1.2k
Morten S. Thomsen Denmark 21 731 1.4× 351 1.6× 133 0.8× 24 0.2× 37 0.4× 36 976
Mattias Rickhag Denmark 15 461 0.9× 413 1.8× 43 0.3× 71 0.5× 89 1.0× 26 898
Rosa Luisa Potenza Italy 21 455 0.9× 699 3.1× 104 0.6× 49 0.3× 52 0.6× 38 1.2k
Talene A. Yacoubian United States 22 799 1.5× 512 2.3× 110 0.7× 154 1.0× 150 1.6× 38 1.5k
Barbara Riozzi Italy 20 576 1.1× 707 3.1× 76 0.4× 105 0.7× 41 0.5× 30 1.2k
Jennifer E. Chubb United Kingdom 4 803 1.5× 223 1.0× 136 0.8× 28 0.2× 40 0.4× 4 1.0k
Mascia Amici United Kingdom 15 594 1.1× 662 2.9× 113 0.7× 73 0.5× 66 0.7× 20 1.2k
Katsunori Tajinda United States 16 383 0.7× 236 1.0× 26 0.2× 156 1.0× 45 0.5× 25 810

Countries citing papers authored by Barbara Langen

Since Specialization
Citations

This map shows the geographic impact of Barbara Langen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Langen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Langen more than expected).

Fields of papers citing papers by Barbara Langen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Langen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Langen. The network helps show where Barbara Langen may publish in the future.

Co-authorship network of co-authors of Barbara Langen

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Langen. A scholar is included among the top collaborators of Barbara Langen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Langen. Barbara Langen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalebic, Nereo, Barbara Langen, Jussi Helppi, Hiroshi Kawasaki, & Wieland Β. Huttner. (2020). In Vivo Targeting of Neural Progenitor Cells in Ferret Neocortex by In Utero Electroporation. Journal of Visualized Experiments. 4 indexed citations
2.
Kalebic, Nereo, Barbara Langen, Jussi Helppi, Hiroshi Kawasaki, & Wieland Β. Huttner. (2020). In Vivo Targeting of Neural Progenitor Cells in Ferret Neocortex by In Utero Electroporation. Journal of Visualized Experiments. 2 indexed citations
3.
Kalebic, Nereo, Carlotta Gilardi, Barbara K. Stepien, et al.. (2019). Neocortical Expansion Due to Increased Proliferation of Basal Progenitors Is Linked to Changes in Their Morphology. Cell stem cell. 24(4). 535–550.e9. 100 indexed citations
4.
Kostić, Miloš, Judith T.M.L. Paridaen, Katherine R. Long, et al.. (2019). YAP Activity Is Necessary and Sufficient for Basal Progenitor Abundance and Proliferation in the Developing Neocortex. Cell Reports. 27(4). 1103–1118.e6. 42 indexed citations
5.
Long, Katherine R., Ben Newland, Marta Florio, et al.. (2018). Extracellular Matrix Components HAPLN1, Lumican, and Collagen I Cause Hyaluronic Acid-Dependent Folding of the Developing Human Neocortex. Neuron. 99(4). 702–719.e6. 130 indexed citations
6.
Kalebic, Nereo, Carlotta Gilardi, Mareike Albert, et al.. (2018). Human-specific ARHGAP11B induces hallmarks of neocortical expansion in developing ferret neocortex. eLife. 7. 79 indexed citations
7.
Müller, Alex, et al.. (2018). Violence against South African sexual and gender minority people: a cross-sectional study. European Journal of Public Health. 28(suppl_4). 1 indexed citations
8.
Nissinen, Liisa, Barbara Langen, Rita Dost, et al.. (2015). Sulfonamide inhibitors of α2β1 integrin reveal the essential role of collagen receptors in in vivo models of inflammation. Pharmacology Research & Perspectives. 3(3). e00146–e00146. 7 indexed citations
9.
Grunwald, Christian, et al.. (2012). Targeting PDE10A in schizophrenia. Drugs of the Future. 37(8). 577–577. 6 indexed citations
10.
Langen, Barbara, et al.. (2011). Effect of PDE10A inhibitors on MK-801-induced immobility in the forced swim test. Psychopharmacology. 221(2). 249–259. 29 indexed citations
11.
12.
Langen, Barbara & Rita Dost. (2010). Comparison of SHR, WKY and Wistar rats in different behavioural animal models: effect of dopamine D1 and alpha2 agonists. ADHD Attention Deficit and Hyperactivity Disorders. 3(1). 1–12. 59 indexed citations
13.
Stange, Hans, Hans‐Joachim Lankau, Christian Grunwald, et al.. (2010). Discovery of Imidazo[1,5-a]pyrido[3,2-e]pyrazines as a New Class of Phosphodiesterase 10A Inhibitiors. Journal of Medicinal Chemistry. 53(11). 4399–4411. 50 indexed citations
14.
Grauer, Steven M., Virginia Pulito, Rachel L. Navarra, et al.. (2009). Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia. Journal of Pharmacology and Experimental Therapeutics. 331(2). 574–590. 223 indexed citations
15.
Bert, Bettina, et al.. (2006). Clomipramine and selegiline: do they influence impulse control?. Journal of Veterinary Pharmacology and Therapeutics. 29(1). 41–47. 10 indexed citations
16.
Langen, Barbara & Chris Rundfeldt. (2006). ELB139 an agonist at the benzodiazepine binding site increases 5-HT in the striatum and prefrontal cortex of rats: a microdialysis study. Pharmacology Biochemistry and Behavior. 86(1). 79–85. 2 indexed citations
17.
18.
Langen, Barbara, Rita Dost, & Chris Rundfeldt. (2005). Antipsychotic effect of the alpha–3 subunit selective benzodiazepine agonist ELB139 in rats. Pharmacopsychiatry. 38(5). 1 indexed citations
19.
Langen, Barbara & Heidrun Fink. (2004). Anxiety as a predictor of alcohol preference in rats?. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(6). 961–968. 24 indexed citations
20.
Langen, Barbara, Silke Dietze, & Heidrun Fink. (2002). Acute effect of ethanol on anxiety and 5-HT in the prefrontal cortex of rats. Alcohol. 27(2). 135–141. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026